Hormone Therapy for Prostate Cancer Jacksonville FL

Hormone therapy to treat advanced prostate cancer can increase the risk of heart disease, but some types of hormone therapy appear to be safer than others, new research has found. The study included 30,642 Swedish men with either locally advanced prostate cancer or prostate cancer that had spread (metastatic cancer), who had received hormone therapy as primary treatment for their cancer.

Michael James Erhard, MD
(904) 390-3747
807 Childrens Way
Jacksonville, FL
Specialties
Urology
Gender
Male
Education
Medical School: Jefferson Med Coll-Thos Jefferson Univ, Philadelphia Pa 19107
Graduation Year: 1989
Hospital
Hospital: Baptist Med Ctr, Jacksonville, Fl
Group Practice: Nemours Children's Clinic

Data Provided by:
Aseem Ravindra Shukla, MD
(904) 390-3747
807 Childrens Way
Jacksonville, FL
Specialties
Urology
Gender
Male
Education
Medical School: Univ Of South Fl Coll Of Med, Tampa Fl 33612
Graduation Year: 1995

Data Provided by:
Mark A Barraza
(904) 390-3600
807 Childrens Way
Jacksonville, FL
Specialty
Urology

Data Provided by:
Erica Lynne Mercer, MD
(904) 390-3748
807 Childrens Way
Jacksonville, FL
Specialties
Urology
Gender
Female
Education
Medical School: Univ Of Fl Coll Of Med, Gainesville Fl 32610
Graduation Year: 1996

Data Provided by:
Charles Joel Rosser, MD
(904) 244-7340
715 Rio Lindo Dr
Jacksonville, FL
Specialties
Urology
Gender
Male
Education
Medical School: Umdnj-Robt W Johnson Med Sch, New Brunswick Nj 08901
Graduation Year: 1994

Data Provided by:
Fawaz Ashouri, MD
(904) 396-3700
836 Prudential Dr Ste 1606
Jacksonville, FL
Specialties
Urology
Gender
Male
Education
Medical School: Univ Of Aleppo, Fac Of Med, Aleppo, Syria
Graduation Year: 1976

Data Provided by:
Michael J Erhard
(904) 390-3747
807 Childrens Way
Jacksonville, FL
Specialty
Urology

Data Provided by:
Charles Gary Cobb, MD
(972) 580-7690
836 Prudential Dr Ste 1502
Jacksonville, FL
Specialties
Urology
Gender
Male
Education
Medical School: Vanderbilt Univ Sch Of Med, Nashville Tn 37232
Graduation Year: 1992

Data Provided by:
Alan Ronald Eckels, MD
(904) 396-3700
836 Prudential Dr Ste 1606
Jacksonville, FL
Specialties
Urology
Gender
Male
Education
Medical School: Univ Of Fl Coll Of Med, Gainesville Fl 32610
Graduation Year: 1960

Data Provided by:
Erica S Mercer
(904) 390-3747
807 Childrens Way
Jacksonville, FL
Specialty
Urology

Data Provided by:
Data Provided by:

Hormone Therapy for Prostate Cancer

Provided By:

TUESDAY, Sept. 22 (HealthDay News) -- Hormone therapy to treat advanced prostate cancer can increase the risk of heart disease, but some types of hormone therapy appear to be safer than others, new research has found.

The study included 30,642 Swedish men with either locally advanced prostate cancer or prostate cancer that had spread (metastatic cancer), who had received hormone therapy as primary treatment for their cancer.

The study findings were scheduled to be presented Tuesday at the European Cancer Organization meeting in Berlin.

In a news release from the European Cancer Organization, the researchers described the types of hormone therapy used: removal of the testicles to eliminate the main source of testosterone production; injections of gonadotropin-releasing hormone agonists to reduce testosterone production by the testicles; and anti-androgen pills that block testosterone from attaching to prostate cells. Most of the patients received one treatment, but 38 percent were given two types of drugs, the study authors noted.

The men were followed for an average of three years and monitored for ischemic heart disease, heart attacks, arrhythmia, and heart failure.

"We found that prostate cancer patients treated with hormone therapy had an elevated risk of developing all of the individual types of heart problems and that they were more likely than normal to die from those causes," study lead author Mieke Van Hemelrijck, a cancer epidemiologist at King's College in London, England, said in the news release.

Specifically, hormone therapy was associated with a 24 percent increased risk of heart attack, a 19 percent increased risk of arrhythmia, a 31 percent increased risk of ischemic heart disease, and a 26 percent increased risk of heart failure, the researchers found. The increased risk of heart disease began a few months after the men began hormone therapy.

The study also found that hormone therapy was associated with a 28 percent increased risk of fatal heart attack, a 21 percent increased risk of dying from heart disease, a 26 percent increased risk of death from heart failure, and a 5 percent increased risk of fatal arrhythmia.

"In a more detailed analysis by type of hormone therapy, the lowest increase in risk for ischemic heart disease, heart attack and heart failure was seen in the group taking anti-androgen therapy, and we saw no increase in risk of death from heart disease in this group. Patients on gonadotropin-releasing hormone agonist therapy had the highest risk of these problems," Van Hemelrijck said.

The findings suggest that physicians should consider heart-related side effects when prescribing hormone therapy for prostate cancer patients and may want to refer patients to a cardiologist before the start of hormone therapy, the researchers stated.

More information

The American Urological Association Foundation has more about hormone therapy for prostate cancer.

SOURCE: European Cancer Organization, news release, Sept. 22, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Mailing Address:
Jacksonville Magazine
1261 King St.
Jacksonville, FL 32204
TEL: (904) 389-3622
FAX: (904) 389-3628
E-mail: mail@jacksonvillemag.com